Regulatory Mechanisms Governing Vertebral Segmentation
椎骨分割的调节机制
基本信息
- 批准号:9316666
- 负责人:
- 金额:$ 35.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-07-01 至 2019-07-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectBindingBinding SitesCell Differentiation processCell ProliferationCellsCircadian RhythmsCongenital AbnormalityDefectElementsEmbryonic DevelopmentFeedbackGene ExpressionGene FamilyGenesGeneticGenetic TranscriptionHeterogeneous-Nuclear RibonucleoproteinsHumanInformatinMalignant NeoplasmsMapsMass Spectrum AnalysisMathematicsMeasuresMessenger RNAMissionModelingMusMutationOvaryPacemakersPathway interactionsPatternPeriodicityProcessProtein FamilyProteinsRNA BindingRNA DecayRNA-Binding ProteinsRoleSegmentation Clock PathwayStem cellsTestingTimeTissue TherapyTissuesTranscription Repressor/CorepressorUbiquitinUnited States National Institutes of HealthUntranslated RegionsVertebral columnZebrafishbasebiological systemscancer therapyembryonic stem cellexperimental studygain of functiongene discoveryin vivoloss of functionmRNA Instabilitymalformationmulticatalytic endopeptidase complexnerve stem celloverexpressionpredictive modelingpreventprotein degradationprotein expressionpublic health relevancespine bone structuretranscription factortranscriptome sequencingtumor progression
项目摘要
DESCRIPTION (provided by applicant): Gene expression oscillations are widespread in biological systems. The segmentation clock is one such oscillator controlling segmentation of the vertebral column. Its disruption results in congenital vertebral defects in humans. We have built a mathematical pacemaker model that is based on a transcriptional-feedback loop. Our model predicts that a moderate increase in the stabilities of Her proteins or mRNAs should lengthen the period, while a further increase would abolish the oscillations. To establish the mechanisms of Her protein and mRNA turnover, and to elucidate the mechanism that transfers this periodic information to cells of the next- forming segments, we will: 1. Discover the post-translational mechanism that rapidly recycles oscillating proteins: We will perform loss-of- function experiments for proteins that are candidates to regulate rapid degradation of Her proteins. We will assess whether any of these genes regulate the degradation of the Her-family proteins. Finally, to test the prediction of our model, we will stabilize Her proteins to varying levels by reducing expression of proteins that trigger its degradation and measure corresponding changes in the segmentation process. 2. Discover the post-transcriptional mechanism that rapidly recycles oscillating RNAs: We will determine loss- of-function of which her-RNA-binding proteins stabilize her mRNAs and result in vertebral segmentation defects. We will test the prediction of our model by increasing the halflives of her mRNAs through reduced expression of RNA-binding proteins and determining how the segmentation process is affected. 3. Discover the information transfer mechanism from the segmentation clock to the segmentation machinery: We will perform time-resolved overexpression and loss-of-function experiments for the mesp gene to determine its impact on the segmentation process. We will determine the regulatory cascade starting with the segmentation clock, continuing through the dynamically expressed mesp transcription factor and ending with the formation of segment boundaries. Hes proteins also oscillate in neural progenitor cells, ovary cells and embryonic stem cells, where the oscillations appear to control the temporal switch from proliferation to differentiation. Gain-of-function of Hes proteins is correlated with cancer and their inhibition restores differentiation. Elucidating the dynamics of the Hes/Her oscillations during vertebral segmentation is significant not only for understanding and potentially preventing vertebral malformations, but also for developing approaches for controlled stem cell proliferation and differentiation in various tissues and therapies against cancer progression. Therefore, this application has strong relevance to the mission of the National Institute of Health.
描述(由申请人提供):基因表达振荡在生物系统中广泛。分割时钟是椎骨列的控制分割的振荡器之一。它的破坏会导致人类先天性椎骨缺陷。我们已经建立了基于转录反馈循环的数学起搏器模型。我们的模型预测,她的蛋白质或mRNA的稳定性适度增加应延长时期,而进一步的增加将消除振荡。为了建立其蛋白质和mRNA转换的机制,并阐明将此周期性信息转移到下一个细分细胞的细胞的机制,我们将:1。发现迅速循环循环振荡蛋白质的翻译后机制:我们将对蛋白质造成损失的蛋白质,以调节蛋白质,以调节蛋白质的快速降级。我们将评估这些基因中的任何一个是否调节其家庭蛋白质的降解。最后,为了测试我们的模型的预测,我们将通过减少蛋白质的表达来稳定其蛋白质的水平,从而触发其降解并测量分割过程中的相应变化。 2。发现快速回收振荡RNA的转录后机制:我们将确定其损失的功能,其中Her-RNA结合蛋白可以稳定其mRNA并导致椎骨分割缺陷。我们将通过降低RNA结合蛋白的表达并确定分割过程的影响如何通过增加其mRNA的半镜来测试模型的预测。 3。发现从分割时钟到分割机械的信息传输机制:我们将对MESP基因执行时间分辨的过表达和功能丧失实验,以确定其对分割过程的影响。我们将从分段时钟开始,通过动态表达的MESP转录因子继续进行调节级联,并以段边界的形成结束。 HES蛋白还会在神经祖细胞,卵巢细胞和胚胎干细胞中振荡,其中振荡似乎控制了从增殖到分化的时间切换。 HES蛋白的功能收益与癌症及其抑制作用恢复分化相关。阐明在椎骨分割过程中HES/她的振荡动力学不仅对于理解和潜在预防椎骨畸形,而且对于开发用于各种组织和针对癌症进展的各种组织和疗法的受控方法的方法都非常重要。因此,该申请与国家卫生研究院的使命有很强的相关性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ertugrul M Ozbudak其他文献
Ertugrul M Ozbudak的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ertugrul M Ozbudak', 18)}}的其他基金
Integration of spatiotemporal signaling for pattern formation and scaling
整合时空信号以形成模式和缩放
- 批准号:
10656503 - 财政年份:2021
- 资助金额:
$ 35.1万 - 项目类别:
Integration of spatiotemporal signaling for pattern formation and scaling
整合时空信号以形成模式和缩放
- 批准号:
10489850 - 财政年份:2021
- 资助金额:
$ 35.1万 - 项目类别:
Regulatory Mechanisms Governing Precision in Vertebral Segmentation
控制椎体分割精度的调节机制
- 批准号:
10162773 - 财政年份:2021
- 资助金额:
$ 35.1万 - 项目类别:
Regulatory Mechanisms Governing Precision in Vertebral Segmentation
控制椎体分割精度的调节机制
- 批准号:
10406991 - 财政年份:2021
- 资助金额:
$ 35.1万 - 项目类别:
Regulatory Mechanisms Governing Precision in Vertebral Segmentation
控制椎体分割精度的调节机制
- 批准号:
10584604 - 财政年份:2021
- 资助金额:
$ 35.1万 - 项目类别:
Integration of spatiotemporal signaling for pattern formation and scaling
整合时空信号以形成模式和缩放
- 批准号:
10295895 - 财政年份:2021
- 资助金额:
$ 35.1万 - 项目类别:
Elucidating the Mechanism of Precision in Vertebral Segmentation
阐明椎骨分割的精确机制
- 批准号:
9889967 - 财政年份:2017
- 资助金额:
$ 35.1万 - 项目类别:
Elucidating the Mechanism of Precision in Vertebral Segmentation
阐明椎骨分割的精确机制
- 批准号:
9287967 - 财政年份:2017
- 资助金额:
$ 35.1万 - 项目类别:
Regulatory Mechanisms Governing Vertebral Segmentation
椎骨分割的调节机制
- 批准号:
8930167 - 财政年份:2014
- 资助金额:
$ 35.1万 - 项目类别:
Regulatory Mechanisms Governing Vertebral Segmentation
椎骨分割的调节机制
- 批准号:
8766216 - 财政年份:2014
- 资助金额:
$ 35.1万 - 项目类别:
相似国自然基金
Tva受体结合K亚群禽白血病病毒gp85影响病毒易感宿主范围的分子机制
- 批准号:32302908
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
改性水泥基材料氯离子结合稳定性及其对钢筋锈蚀萌生的影响机制研究
- 批准号:52378276
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
鸡DEC 205结合肽的鉴定及其影响黏膜递送效率的研究
- 批准号:32302909
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
ALK融合伴侣结合蛋白通过空间位阻效应影响ALKoma异质性的分子机制
- 批准号:82303945
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
喀斯特森林林隙对土壤矿物结合有机碳积累与稳定的影响机制
- 批准号:32360385
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
相似海外基金
Developing and Evaluating a Positive Valence Treatment for Alcohol Use Disorder with Anxiety or Depression
开发和评估治疗伴有焦虑或抑郁的酒精使用障碍的正价疗法
- 批准号:
10596013 - 财政年份:2023
- 资助金额:
$ 35.1万 - 项目类别:
Endothelial Cell Reprogramming in Familial Intracranial Aneurysm
家族性颅内动脉瘤的内皮细胞重编程
- 批准号:
10595404 - 财政年份:2023
- 资助金额:
$ 35.1万 - 项目类别:
The role and mechanism of RNA m6A modification in the pathogenesis and drug-resistance of prostate cancer
RNA m6A修饰在前列腺癌发病及耐药中的作用及机制
- 批准号:
10638634 - 财政年份:2023
- 资助金额:
$ 35.1万 - 项目类别:
Dravet Syndrome Anti-Epileptic Control by Targeting GIRK Channels
通过针对 GIRK 通道进行 Dravet 综合征抗癫痫控制
- 批准号:
10638439 - 财政年份:2023
- 资助金额:
$ 35.1万 - 项目类别:
Novel application of pharmaceutical AMD3100 to reduce risk in opioid use disorder: investigations of a causal relationship between CXCR4 expression and addiction vulnerability
药物 AMD3100 降低阿片类药物使用障碍风险的新应用:CXCR4 表达与成瘾脆弱性之间因果关系的研究
- 批准号:
10678062 - 财政年份:2023
- 资助金额:
$ 35.1万 - 项目类别: